Review Article

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

Table 1

Risk categories according to FLIPI index.

Risk groupNumber of factorsDistribution of patients (%)5-year OS, % (SE)10-year OS, % (SE)RR95% CI

Low0-13690.6 (1.2)70.7 (2.7)1.0NA
Intermediate23777.6 (1.6)50.9 (2.7)2.31.9–2.8
High≥32752.5 (2.3)35.5 (2.8)4.33.5–5.3